Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mizoribine in Active Rheumatoid Arthritis
NCT02005757Phase 2Unknown
- Sponsor
- Chong Kun Dang Holdings
- Start
- Nov 2013
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mizoribine in rheumatoid arthritis (RA), sponsored by Chong Kun Dang Holdings. Status: unknown.
02
Drugs
mizoribine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02005757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02005757.